These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37773589)

  • 1. Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling.
    Bakbak E; Verma S; Krishnaraj A; Quan A; Wang CH; Pan Y; Puar P; Mason T; Verma R; Terenzi DC; Rotstein OD; Yan AT; Connelly KA; Teoh H; Mazer CD; Hess DA
    Am J Physiol Heart Circ Physiol; 2023 Nov; 325(5):H1210-H1222. PubMed ID: 37773589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes.
    Park B; Krishnaraj A; Teoh H; Bakbak E; Dennis F; Quan A; Hess DA; Verma S
    Am J Physiol Heart Circ Physiol; 2024 Aug; 327(2):H370-H376. PubMed ID: 38874618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial.
    Bakbak E; Krishnaraj A; Bhatt DL; Quan A; Park B; Bakbak AI; Bari B; Terenzi KA; Pan Y; Fry EJ; Terenzi DC; Puar P; Khan TS; Rotstein OD; Mazer CD; Leiter LA; Teoh H; Hess DA; Verma S
    Med; 2024 Jul; 5(7):718-734.e4. PubMed ID: 38552629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus.
    Hess DA; Terenzi DC; Trac JZ; Quan A; Mason T; Al-Omran M; Bhatt DL; Dhingra N; Rotstein OD; Leiter LA; Zinman B; Sabongui S; Yan AT; Teoh H; Mazer CD; Connelly KA; Verma S
    Cell Metab; 2019 Oct; 30(4):609-613. PubMed ID: 31477497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
    Connelly KA; Mazer CD; Puar P; Teoh H; Wang CH; Mason T; Akhavein F; Chang CW; Liu MH; Yang NI; Chen WS; Juan YH; Opingari E; Salyani Y; Barbour W; Pasricha A; Ahmed S; Kosmopoulos A; Verma R; Moroney M; Bakbak E; Krishnaraj A; Bhatt DL; Butler J; Kosiborod MN; Lam CSP; Hess DA; Rizzi Coelho-Filho O; Lafreniere-Roula M; Thorpe KE; Quan A; Leiter LA; Yan AT; Verma S
    Circulation; 2023 Jan; 147(4):284-295. PubMed ID: 36335517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular Regenerative Cell Deficiencies in South Asian Adults.
    Krishnaraj A; Bakbak E; Teoh H; Pan Y; Firoz IN; Pandey AK; Terenzi DC; Verma R; Bari B; Bakbak AI; Kunjummar SP; Yanagawa B; Connelly KA; Mazer CD; Rotstein OD; Quan A; Bhatt DL; McGuire DK; Hess DA; Verma S
    J Am Coll Cardiol; 2024 Feb; 83(7):755-769. PubMed ID: 38355246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
    Verma S; Mazer CD; Yan AT; Mason T; Garg V; Teoh H; Zuo F; Quan A; Farkouh ME; Fitchett DH; Goodman SG; Goldenberg RM; Al-Omran M; Gilbert RE; Bhatt DL; Leiter LA; Jüni P; Zinman B; Connelly KA
    Circulation; 2019 Nov; 140(21):1693-1702. PubMed ID: 31434508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes: Translational Insights Into the Prevention of Ischemic Complications in Diabetes.
    Terenzi DC; Al-Omran M; Quan A; Teoh H; Verma S; Hess DA
    JACC Basic Transl Sci; 2019 Feb; 4(1):98-112. PubMed ID: 30847424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we go beyond surrogates?
    Drexler A
    J Diabetes; 2017 Nov; 9(11):976-977. PubMed ID: 28692750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded Hematopoietic Progenitor Cells Reselected for High Aldehyde Dehydrogenase Activity Demonstrate Islet Regenerative Functions.
    Seneviratne AK; Bell GI; Sherman SE; Cooper TT; Putman DM; Hess DA
    Stem Cells; 2016 Apr; 34(4):873-87. PubMed ID: 26676482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical cord blood-derived aldehyde dehydrogenase-expressing progenitor cells promote recovery from acute ischemic injury.
    Putman DM; Liu KY; Broughton HC; Bell GI; Hess DA
    Stem Cells; 2012 Oct; 30(10):2248-60. PubMed ID: 22899443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Aldehyde Dehydrogenase Activity Identifies a Subset of Human Mesenchymal Stromal Cells with Vascular Regenerative Potential.
    Sherman SE; Kuljanin M; Cooper TT; Putman DM; Lajoie GA; Hess DA
    Stem Cells; 2017 Jun; 35(6):1542-1553. PubMed ID: 28295901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study.
    Rau M; Thiele K; Hartmann NK; Schuh A; Altiok E; Möllmann J; Keszei AP; Böhm M; Marx N; Lehrke M
    Cardiovasc Diabetol; 2021 Jan; 20(1):6. PubMed ID: 33413355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapancreatic delivery of human umbilical cord blood aldehyde dehydrogenase-producing cells promotes islet regeneration.
    Bell GI; Putman DM; Hughes-Large JM; Hess DA
    Diabetologia; 2012 Jun; 55(6):1755-60. PubMed ID: 22434536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
    Lee MMY; Brooksbank KJM; Wetherall K; Mangion K; Roditi G; Campbell RT; Berry C; Chong V; Coyle L; Docherty KF; Dreisbach JG; Labinjoh C; Lang NN; Lennie V; McConnachie A; Murphy CL; Petrie CJ; Petrie JR; Speirits IA; Sourbron S; Welsh P; Woodward R; Radjenovic A; Mark PB; McMurray JJV; Jhund PS; Petrie MC; Sattar N
    Circulation; 2021 Feb; 143(6):516-525. PubMed ID: 33186500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of mobilized peripheral stem cells according to CD34 and aldehyde dehydrogenase expression and effect of SSC(lo) ALDH(br) cells on hematopoietic recovery.
    Gündüz E; Demirel G; Bal C; Gulbas Z
    Cytotherapy; 2010 Dec; 12(8):1006-12. PubMed ID: 20735165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.
    Cherney DZI; Zinman B; Inzucchi SE; Koitka-Weber A; Mattheus M; von Eynatten M; Wanner C
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):610-621. PubMed ID: 28666775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.
    Tanaka A; Shimabukuro M; Okada Y; Taguchi I; Yamaoka-Tojo M; Tomiyama H; Teragawa H; Sugiyama S; Yoshida H; Sato Y; Kawaguchi A; Ikehara Y; Machii N; Maruhashi T; Shima KR; Takamura T; Matsuzawa Y; Kimura K; Sakuma M; Oyama JI; Inoue T; Higashi Y; Ueda S; Node K;
    Cardiovasc Diabetol; 2017 Apr; 16(1):48. PubMed ID: 28403850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications.
    Heerspink HJ; Perkins BA; Fitchett DH; Husain M; Cherney DZ
    Circulation; 2016 Sep; 134(10):752-72. PubMed ID: 27470878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of empagliflozin on erythropoiesis in patients with type 2 diabetes: Data from a randomized, placebo-controlled study.
    Thiele K; Rau M; Hartmann NK; Möllmann J; Jankowski J; Böhm M; Keszei AP; Marx N; Lehrke M
    Diabetes Obes Metab; 2021 Dec; 23(12):2814-2818. PubMed ID: 34378852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.